To assess the effect of hemodialysis on protein metabolism, leucine flux was measured in seven patients before, during, and after high efficiency hemodialysis using cuprophane dialyzers and bicarbonate dialysate during a primed-constant infusion of L-I1-'3CIleucine. The kinetics ;Lsmol/kg per h, mean±SDJ are as follows: leucine appearance into the plasma leucine pool was 86±28, 80±28, and 85±25, respectively, before, during, and after dialysis. Leucine appearance into the whole body leucine pool, derived from plasma l1-'3Cla-ketoisocaproate enrichment, was 118±31, 118±31, and 114±28 before, during, and after dialysis, respectively. In the absence of leucine intake, appearance rate reflects protein degradation, which was clearly unaffected by dialysis. Leucine oxidation rate was 17.3±7.8 before, decreased to 13.8±7.8 during, and increased to 18.9±10.3 after dialysis (P = 0.027). Leucine protein incorporation was 101±26 before, was reduced to 89±23 during, and returned to 95±23 after dialysis (P = 0.13). Leucine net balance, the difference between leucine protein incorporation and leucine release from endogenous degradation, was -173±7.8 before, decreased to -28.5±11.0 during, and returned to -18.9±10.3 after dialysis (P < 0.0001). This markedly more negative leucine balance during dialysis was accountable by dialysate leucine loss, which was 14.4±6.2 umol/kg per h. These data suggest that hemodialysis using a cuprophane membrane did not acutely induce protein degradation. It was, nevertheless, a net catabolic event because protein synthesis was reduced and amino acid was lost into the dialysate. (J. Clin. Invest. 1993 91:2429-2436
Introduction
It is generally believed that hemodialysis is a protein catabolic process (1) (2) (3) . This notion stems from the observation of that blood urea nitrogen rebounds rapidly after dialysis and the fact that 6-8 g ofamino acids are lost to the dialysate per treatment (4) (5) (6) . Furthermore, Farrell and colleagues (7) and Ward et al. (8) noted that urea generation rate, calculated from urea ki-netics, is 30% higher during dialysis than during the interdialytic period. Using metabolic balance technique, Borah et al. (9) noted that nitrogen balance is always less on the day of dialysis irrespective of the quantity of protein intake, and we have noted that dialysate nitrogen loss per day tends to be greater when the interdialytic interval is shorter ( 10) . None of these studies, however, provide unequivocal evidence of dialysis-induced protein breakdown. The rapid rebound of urea nitrogen after dialysis could be explained on the basis of intercompartmental redistribution and equilibration ( 11). Nitrogen balance studies are limited by their inherent methodological inaccuracies and are able to measure only net changes in protein metabolism ( 12). The mathematics of urea kinetics permit calculation of urea generation rate per dialysis cycle (from the end of one dialysis to the end ofthe next) but cannot reliably sort out the differences between the intra-and the interdialytic periods ( 13). The most convincing evidence of hemodialysis-induced protein breakdown is reported by Gutierrez and colleagues ( 14) , showing that circulation of blood through a dialyzer without dialysate increased amino acid release from the leg, suggesting that contact of blood with the dialysis membrane led to proteolysis.
To address more directly the issue of dialysis-induced protein catabolism, we used the technique of primed-constant infusion of L- [1-I3C] leucine, a tracer amino acid, for estimation of whole body protein flux before, during, and for 4 h after hemodialysis.
Methods
Study subjects and dialysis prescription. Seven hemodialysis patients were recruited for this study; their demographic, nutritional, and dialysis status are listed in Table I . All participants were clinically stable and without intercurrent acute illness. There were four women and three men; their ages ranged from 20 to 56 yr. Diagnoses included four with chronic glomerulonephritis and one each with hypertensive nephrosclerosis, adult polycystic kidney disease, and medullary cystic kidney disease. All patients were in stable clinical condition and none had diabetes mellitus. With the exception ofJ.D., serum albumin was normal in all participants. Their medication consisted of phosphate binders and multivitamins and, in J.D., Enalapril (Merck, Sharp Procedures. Subjects were admitted to the Clinical Research Center the day before the study. After a 12-h overnight fast, leucine infusion was started at 0700 the next morning. Gauge 20 needles were inserted into the arterial and the venous ends of the vascular access, the former for blood sampling and the latter for infusion. Isotopic [1-13C] leucine (see below) was infused for 4 h from 0700 to 1100 hours before dialysis, continued for 2.5 h during high efficiency hemodialysis, and for 4 h after dialysis (total infusion time was 10.5 h). The first 2 h of the infusion was used to achieve isotopic equilibrium; data from the third and fourth hours served as the predialysis baseline to which dialysis and postdialysis values were compared. CO2 production rate (FCO2), atom percent excess of [1-I3C] leucine and [1-13C] KIC in the plasma, and atom percent excess of '3CO2 in the expired gas were quantitated before infusion and every 30 min for 2 h before, during, and 4 h after dialysis. Additionally, total plasma leucine concentration was measured before, during, and after dialysis. Spent dialysate was also collected during the study and, after appropriate mixing, aliquots were taken for measurement of leucine concentration. Quantitation of amino acid metabolism was on the basis of the relationship stating that Q = S + C = B + I, where Q is flux or total turnover rate, S is the rate of amino acid incorporation into protein or protein synthesis, C is the rate ofamino acid oxidation, B represents the rate of amino acid release from endogenous protein breakdown, and I is the rate of exogenous intake. In the postabsorptive state, I equals 0 and B, therefore, equals Q. In general, routes of nonoxidative leucine disposal other than S are assumed to be negligible ( 12, 19) . This statement is true in the pre-and postdialysis period when S = Q -C. During dialysis, when nonoxidative disposal of leucine must take into account dialysate loss, then S = Q -(C + D) where D equals dialysate leucine loss. Leucine loss was measured in the spent dialysate and the loss was assumed to be linear during the entire 2.5 h of treatment. Net B or net leucine balance was derived from the difference between leucine protein incorporation (S) and leucine degradation (D); the latter being equal to Q or flux.
Leucine To account for the changes in the natural abundance of '3CO2 in expired gas during dialysis, additional studies were performed in four subjects in whom expired gases were collected as described below before, during, and after identical hemodialysis but in the absence of L-[1-'3CJ leucine and NaH '3CO3 administration. The average change in expired 13CO2 enrichment of these four subjects at each dialysis and postdialysis period was subtracted from individual measured values of all study subjects during the same experimental period to yield corrected values for '3CO2 enrichment that were then used in above equations to generate data on leucine oxidation and leucine protein incorporation.
Leucine and CO2 measurement. [1 13C] -enrichment ofplasma leucine and plasma KIC was measured by gas chromatography mass spectrometry (22, 23) and 13CO2 enrichment in the expired gas was measured by isotope ratio mass spectrometry as described previously ( 16) .
Leucine content in the plasma and the spent dialysate was measured by an amino acid analyzer (model 6300; Beckman Instruments, Inc., Fullerton, CA) using norleucine as the internal standard (24) . The data were analyzed using Waters Expert Ver. 6.2 IA software (Waters Instrs. Inc., Rochester, MN).
CO2 production rate and collection ofexpired gas. C02 production rate [FCO2] was determined by a portable metabolic gas monitor [model MGMII; Utah Medical Products, Midvale, UT]. Subjects were given sufficient time to become familiarized with the equipment and the procedures. During measurement, a mouthpiece attached to a twoway valve was used. Expired gas was sampled by a small gas line leading from the mouthpiece to an infrared CO2 sensor. Simultaneously, tidal volume and frequency of respiration were recorded by a pneumotacograph and expired ventilation by an ultrasonic flow transducer (25) . Partial pressure of the inspired CO2 was taken from that of the atmosphere. Fco2 was calculated by standard equations and corrected for standard pressure and temperature, dry. Before each experiment, the equipment was calibrated with a standard reference gas consisting of 10% CO2 and the flow transducer was checked by a calibrated syringe. Immediately after each measurement, the expired gas was collected into a Douglas bag and a sample was transferred anaerobically into sealed vacuum tubes (Venoject; Terumo Medical, Elkton, MO) for quantitation of 13CO2 enrichment by isotope ratio mass spectrometry.
Arterial blood gas and serum bicarbonate. Arterial pH, Pco2, and serum bicarbonate concentration were measured before, at 60 and 90 min during dialysis, and immediately after dialysis. These measurements were determined to estimate CO2 and bicarbonate fluxes during the dialysis procedure (see Table IV ). Bicarbonate gain = (post-HCO3 -pre-HCO ) X (BWX 0.4), where HCO3 represents serum bicarbonate levels post-and predialysis, BWis post dialysis body weight, and 0.4 represents bicarbonate distribution space or 40% of body weight. This 40% distribution appears to be appropriate for the pH ranges of our patients, 7.33-7.45 (26) . Bicarbonate loss = [(pre-HCO-+ post-HCO )/2] x UF, where UF is ultrafiltration or fluid removal during dialysis. Net HCO-gain is the difference between HCO-gain and loss. If all the bicarbonate gained from the dialysate were to be titrated to CO2, the predicted maximal amount of CO2 release = (Net HCO3 gain/ 150) x 24, where 150 is the number ofminutes in 2.5 h ofdialysis and 24 is Avogadro's number, stating that 1 mol of CO2 occupies a volume of 24 liters, and converts CO2 from mmol to ml.
Statistical analysis. Data were stored in the Clinfo System of the Clinical Research Center of the University of Iowa College of Medicine; statistical analyses were completed using analysis of variance and Duncan's multiple comparison test. Table II summarizes leucine appearance rate into the plasma leucine and the total body leucine pools, the former was derived from plasma [1-'3C]leucine enrichment, and the latter derived from plasma [1-'3CJ KIC enrichment (20, 21) . The appearance rates were within normal ranges, stable during the entire 10.5 h of observation, and were unaffected by hemodialysis. (Table IV) as complete plasma clearance of '3C02 into the dialysate on each pass, D'3C02 was overestimated to some extend but was, nonetheless, only -5% of the '3C02 appearance rate (Table III ). The net result, then, was little overall effect on oxidation compared with labeled leucine carbon lost via the breath alone. Fig. 2 illustrates changes in leucine flux, oxidation, protein incorporation, and net leucine balance during and after hemodialysis plotted as percentages of values obtained predialysis. Fig. 2 A shows virtually no fluctuations in leucine appearance rate into the total body leucine pool. By contrast, Fig. 2 B illustrates that leucine oxidation rate decreased to 75% ofbaseline during dialysis and rose to a peak of 130% 4 h after dialysis. Leucine protein incorporation rate, shown in Fig. 2 C, decreased to 83% of baseline during dialysis, rose in the first 2 h after-dialysis, but declined again 4 h later. Most importantly, net leucine balance, depicted as percent change from baseline in Fig. 2 D, showed a reduction by as much as 88% during dialysis compared with the predialysis value. Table V presents the data of oxidative and nonoxidative leucine disposal in a detailed fashion by separating the intradialysis period into 60-and 1 50-min intervals and the postdialysis period into four hourly segments. During dialysis, leucine protein incorporation rate was significantly reduced, from 101 predialysis to 84 ,umol/kg per h. This reduction was not due to increased leucine oxidation (which in fact was reduced) but was in part accountable by dialysate leucine loss ( 14.4 i4mol/kg per h, 15% of leucine appearance rate into the total body leucine pool). After dialysis, leucine protein incorporation rate returned towards normal level, only to become reduced 3 h later; this time it was accompanied by an increase in leucine oxidation. Although leucine oxidation rates in the pre-and postdialysis periods were derived solely from expired gas '3CO2, oxidation rates during dialysis represent the sum of expired gas and dialysate '3CO2 losses. The amount of dialysate 3CO2 loss, however, was minimal, 5% of the expired gas 13C02 appearance rate. Because ofthe combination ofdialysate leucine loss and reduced leucine protein incorporation, net leucine balance was markedly reduced during dialysis.
Since all measurements during the predialysis period were stable, the values were averaged into one single predialysis mean to which intra-and postdialysis measurements were compared. Fig. 3 depicts the kinetics (,umol/kg per h, mean±SD) grouped into three periods. Leucine appearance into the total body leucine pool (Q), was stable, 118±31, 118±31, and 114±28, respectively, before, during, and after dialysis (P = 0.813). By contrast, leucine oxidation rate (C) fell from a pre-dialysis value of 17.3±7.8 to 13.8±7.8 during dialy- In our study, the labeled leucine was infused into the free amino acid pool, plasma in this instance. Dilution ofthe labeled leucine could occur either by leucine intake or degradation ofbody protein with release of unlabeled leucine. Since our experiment was done in the postabsorptive state, the magnitude of the isotopic dilution is proportional to proteolysis because intake = 0, and leucine, and essential amino acid, could be derived only from protein breakdown. On the basis of these leucine appearance rates, we conclude that hemodialysis, as performed in our unit, using a cuprophane membrane, bicarbonate dialysate, and treated water with zero bacteria colony counts, did not directly stimulate protein degradation acutely. The postdialysis blood urea nitrogen rebound must, therefore, be explained on the basis of urea dysequilibrium and redistribution (11). In contrast to the marked stability of the leucine appearance rates, leucine oxidation and leucine protein incorporation rates fluctuated significantly throughout the study ( We did not measure labeled bicarbonate dialysate loss but have calculated its potential loss on the basis of the worse scenario that plasma H 13CO-is totally cleared during each pass through the dialyzer and that the direction of flux is entirely from the blood to the dialysate. Such calculations increased the estimated leucine oxidation rate and yielded a further reduction in leucine protein incorporation rate and a greater negative net leucine balance during dialysis. Because the calculations did not alter the overall conclusions of this work and are fraught with assumptions, the derived data are not included in this paper. It should be emphasized that during bicarbonate dialysis, the major route of bicarbonate/CO2 loss is via the lungs, 533 mmol/h, and not the dialyzer, which lost only 31 mmol/h (Tables III and IV) .
These findings are consistent with the report of Borah et al. (9) , documenting that nitrogen balance is always less on the day of dialysis, and with our own data showing that lengthening the interdialytic interval tends to improve nitrogen balance (10) . By measuring arterio-venous amino acid gradient and total blood flow across the leg, Gutierrez and colleagues ( 14) found that 150 min of sham hemodialysis in normal control subjects led to increased amino acid release, suggesting accelerated protein breakdown. If our patients had a twofold increase in amino acid release, we should have observed a marked reduction in plasma [1-'3C]leucine and [1-3C]KIC enrichment and an increase in the calculated leucine flux, and we did not. Moreover, we found changes during dialysis whereas Gutierrez and associates ( 14) detected changes after dialysis. These discrepancies are difficult to reconcile and may be related to differences in the techniques used.
Our inability to find a change in plasma isotopic dilution could not be due to technical difficulty as the method of primed-constant infusion of a stable isotope is sufficiently sensitive to detect as little as a 2% change in flux rate (12, 16) . Recycling of labeled leucine may mask an increase in leucine flux, although label recycling is usually not a significant problem for the first 6-8 h ofisotope infusion. Our study was 10.5-h long; thus it is possible that we might have missed a small increase in flux in the latter part of the experimental period.
The amount ofleucine lost into the dialysate, 2.26 mmol or 296 mg, was similar to that reported by Wolfson et al. (6) .
Despite this removal, serum leucine level was not reduced during dialysis and actually rose modestly after dialysis. The maintenance of a constant leucine level must be regulated by a balance between catabolism and anabolism. In our study, leucine protein incorporation rate, on the basis of plasma [1-`3CJ KIC enrichment, was reduced from a predialysis value of 101 to a nadir of 84 gmol/kg per h during dialysis (Table V) . This magnitude of reduction would actually provide 2.86 mmol of free leucine on the basis of a mean body weight of 67.3 kg in our subjects. This amount is very close to the measured dialysate loss, 2.26 mmol. Thus, maintenance of a stable serum leucine level in our study was the result of reduced leucine incorporation into protein.
Finally, it should be emphasized that our data pertain only to acute changes during and immediately after dialysis and do not necessarily exclude the possibility that repeated cytokine release with hemodialysis might enhance protein catabolism over a long period of time (30, 31 ) .
In summary, we found that hemodialysis using a cuprophane membrane and bicarbonate dialysate did not increase protein degradation because leucine appearance rates were stable. The procedure, nevertheless, was a net catabolic event because protein synthesis was reduced and there was a net loss of amino acids into the spent dialysate.
